JP Morgan Chase’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-284,400
Closed -$418K 7626
2024
Q4
$418K Hold
284,400
﹤0.01% 5136
2024
Q3
$424K Hold
284,400
﹤0.01% 5009
2024
Q2
$356K Buy
+284,400
New +$369K ﹤0.01% 4858
2024
Q1
Sell
-140,000
Closed -$211K 7753
2023
Q4
$211K Hold
140,000
﹤0.01% 5365
2023
Q3
$224K Hold
140,000
﹤0.01% 5003
2023
Q2
$304K Buy
+140,000
New +$219K ﹤0.01% 4817
2022
Q4
Sell
-600
Closed -$1K 6864
2022
Q3
$1K Hold
600
﹤0.01% 6354
2022
Q2
$2K Hold
600
﹤0.01% 6290
2022
Q1
$2K Sell
600
-19,200
-97% -$67.8K ﹤0.01% 6430
2021
Q4
$95K Sell
19,800
-2,400
-11% -$9.71K ﹤0.01% 5709
2021
Q3
$81K Hold
22,200
﹤0.01% 5675
2021
Q2
$90K Buy
22,200
+2,800
+14% +$11K ﹤0.01% 5578
2021
Q1
$83K Sell
19,400
-14,000
-42% -$66.9K ﹤0.01% 5420
2020
Q4
$132K Buy
33,400
+30,400
+1,013% +$127K ﹤0.01% 4934
2020
Q3
$10K Buy
+3,000
New +$12.7K ﹤0.01% 5258
2016
Q1
Sell
-100,000
Closed -$1M 4862
2015
Q4
$1M Hold
100,000
﹤0.01% 3116
2015
Q3
$841K Buy
+100,000
New +$1.32M ﹤0.01% 3204

Other funds holding OPK

JP Morgan Chase's OPK Position: Q1 2026 in Review

JP Morgan Chase reduced its Opko Health (OPK) stake by 12% in Q1 2026, selling an estimated $87.8K and leaving 508,484 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #4924.

JP Morgan Chase first reported a position in OPK in Q2 2013 and has held it in 45 quarters since. The position peaked at $10.6M in Q4 2021. 235 funds tracked by Wall St. Rank hold OPK as of Q1 2026.

  • JP Morgan Chase held 508,484 shares of Opko Health worth $559K as of Q1 2026.
  • JP Morgan Chase sold 71,294 Opko Health shares in Q1 2026, an estimated $87.8K.
  • Opko Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #4924 holding.
  • JP Morgan Chase first reported a position in Opko Health in Q2 2013 and has held it in 45 quarters since.
  • JP Morgan Chase's Opko Health position peaked at $10.6M in Q4 2021.
  • 235 funds tracked by Wall St. Rank held Opko Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.